Blue Cross, Blue Shield Sue Glaxo For Paxil Patent Gaming

Law360, New York (May 11, 2005, 12:00 AM EDT) -- Once again, GlaxoSmithKline has been accused of gaming the patent system to fend off generic competition for its popular antidepressant Paxil.

Blue Cross and Blue Shield of Minnesota filed a lawsuit against Glaxo on Monday, alleging that the U.K. drug maker manipulated the patent system to keep cheaper generic alternatives from reaching the marketplace.

The lawsuit, filed in U.S. District Court in Minneapolis, claims that Glaxo violated federal and state antitrust laws and fraud laws and engaged in deceptive trade practices.

The lawsuit claims that generics...
To view the full article, register now.